AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12554027 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive health communications (computer-generated telephone or mail messages)
Number of subjects: 21
Study 10850607 — intervention group
Group type: EXPERIMENTAL
Intervention: fentanyl, N2O plus halothane
Number of subjects: 140
Study 10850607 — intervention group
Group type: EXPERIMENTAL
Intervention: fentanyl, N2O plus propofol
Number of subjects: 140
Study 10850607 — intervention group
Group type: EXPERIMENTAL
Intervention: fentanyl, N2O plus isoflurane
Number of subjects: 140
Study 10850607 — intervention group
Group type: COMPARATOR
Intervention: fentanyl and N2O (control group)
Number of subjects: 140
Study 9085959 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet kept inflated for 10 min after I.A. injection of morphine (5 mg in 25 mL saline)
Number of subjects: 40
Study 9085959 — intervention group
Group type: COMPARATOR
Intervention: Tourniquet deflated immediately after I.A. injection of morphine (5 mg in 25 mL saline)
Number of subjects: 40
Study 1492861 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroergocristine (DHEC) 1.5 mg/d
Number of subjects: 80
Study 1492861 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroergocristine (DHEC) 3 mg/d
Number of subjects: 80
Study 1492861 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroergocristine (DHEC) 6 mg/d
Number of subjects: 80
Study 1492861 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 4080903 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.8 ml of pure alcohol per kg body weight)
Number of subjects: 40
Study 4080903 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31208470 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure treatment once per week for 4 weeks and calcipotriol betamethasone ointment once daily for 4 weeks
Number of subjects: 180
Study 31208470 — intervention group
Group type: COMPARATOR
Intervention: Calcipotriol betamethasone ointment once daily for 4 weeks
Number of subjects: 180
Study 29369178 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based cardiac rehabilitation
Number of subjects: 37
Study 29369178 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 37
Study 30592829 — intervention group
Group type: EXPERIMENTAL
Intervention: Balneo-physiotherapeutic procedures including venous laser light, gradient magnetic field, dry carbon dioxide baths, and baths with horse chestnut.
Number of subjects: 0
Study 25850997 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 20 mg once daily
Number of subjects: 52
Study 25850997 — intervention group
Group type: EXPERIMENTAL
Intervention: aPL positive IgG spiking of PNP
Number of subjects: 52
Study 23110952 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (Bc; 16 mg/heifer)
Number of subjects: 28
Study 23110952 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyline (Ac; 3 μg/kg)
Number of subjects: 28
Study 23110952 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine and acyline combined (BcAc)
Number of subjects: 28
Study 23110952 — intervention group
Group type: COMPARATOR
Intervention: Control (Ct)
Number of subjects: 28
Study 20429818 — intervention group
Group type: EXPERIMENTAL
Intervention: Brimonidine/timolol fixed combination (BrTFC) twice daily for 6 weeks
Number of subjects: 25
Study 20429818 — intervention group
Group type: COMPARATOR
Intervention: Dorzolamide/timolol fixed combination (DTFC) twice daily for 6 weeks
Number of subjects: 25
Study 18373654 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen 10 mg four times per day
Number of subjects: 21
Study 18373654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 15661416 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial urinary sphincter implantation (AUS)
Number of subjects: 45
Study 15661416 — intervention group
Group type: COMPARATOR
Intervention: Endourethral macroplastique injection
Number of subjects: 45
Study 12442916 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel (67 mg/m2/week)
Number of subjects: 208
Study 12442916 — intervention group
Group type: COMPARATOR
Intervention: Every 3 weeks paclitaxel (72.7 mg/m2/week)
Number of subjects: 208
Study 12442916 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous steroids
Number of subjects: 208
Study 12442916 — intervention group
Group type: COMPARATOR
Intervention: Oral steroids
Number of subjects: 208
Study 12442916 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel
Number of subjects: 208
Study 10523429 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate emphasis on transference analysis
Number of subjects: 60
Study 10523429 — intervention group
Group type: COMPARATOR
Intervention: Minor or no use of transference analysis
Number of subjects: 60
Study 8549570 — intervention group
Group type: EXPERIMENTAL
Intervention: Swim-bench exercise (SB)
Number of subjects: 6
Study 8549570 — intervention group
Group type: COMPARATOR
Intervention: Arm stroke (AS)
Number of subjects: 6
Study 1777370 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzyme-inducing anticonvulsants (carbamazepine, phenobarbitone or phenytoin)
Number of subjects: 0
Study 1777370 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate
Number of subjects: 0
Study 1777370 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal subjects)
Number of subjects: 0
Study 6094457 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime (50 mg/kg/im route)
Number of subjects: 37
Study 6094457 — intervention group
Group type: COMPARATOR
Intervention: 10-day antibiotic therapy
Number of subjects: 37
Study 30321268 — intervention group
Group type: EXPERIMENTAL
Intervention: Fact Box decision support tools on antibiotics for pneumonia and artificial hydration in advanced dementia (at 1‐month)
Number of subjects: 232
Study 30321268 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 232
Study 28889759 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib with add-on pirfenidone (titrated to 801 mg three times daily)
Number of subjects: 104
Study 28889759 — intervention group
Group type: COMPARATOR
Intervention: Nintedanib alone (150 mg twice daily)
Number of subjects: 104
Study 28889759 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib with add-on pirfenidone
Number of subjects: 104
Study 28889759 — intervention group
Group type: COMPARATOR
Intervention: Nintedanib alone
Number of subjects: 104
Study 26646758 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate print-out LoMoS (intervention)
Number of subjects: 264
Study 26646758 — intervention group
Group type: COMPARATOR
Intervention: No immediate print-out LoMoS (control)
Number of subjects: 264
Study 24628488 — intervention group
Group type: EXPERIMENTAL
Intervention: MTV's 16 and Pregnant
Number of subjects: 0
Study 24628488 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 22109997 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rapamycin plus bare-metal stent (OR + BMS)
Number of subjects: 200
Study 22109997 — intervention group
Group type: COMPARATOR
Intervention: Drug-eluting stents (DES)
Number of subjects: 200
Study 19395185 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation Therapy (RT) 10 Gy
Number of subjects: 450
Study 19395185 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation Therapy (RT) 20 Gy
Number of subjects: 450
Study 19395185 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with doxorubicin (three drugs)
Number of subjects: 450
Study 19395185 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with dactinomycin and vincristine (two drugs)
Number of subjects: 450
Study 19395185 — intervention group
Group type: EXPERIMENTAL
Intervention: Spillage present (Stage II patients)
Number of subjects: 450
Study 19395185 — intervention group
Group type: COMPARATOR
Intervention: Spillage absent (Stage II patients)
Number of subjects: 450
Study 17697416 — intervention group
Group type: EXPERIMENTAL
Intervention: Training by experienced therapists (n=10)
Number of subjects: 20
Study 17697416 — intervention group
Group type: COMPARATOR
Intervention: Training by trained laypersons (n=10)
Number of subjects: 20
Study 16707509 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectant management
Number of subjects: 1200
Study 16707509 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical management
Number of subjects: 1200
Study 16707509 — intervention group
Group type: COMPARATOR
Intervention: Surgical management
Number of subjects: 1200
Study 15275766 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil
Number of subjects: 63
Study 15275766 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 63
Study 10625790 — intervention group
Group type: EXPERIMENTAL
Intervention: Tannenbaum (TB) stent (10F, 7 cm long)
Number of subjects: 57
Study 10625790 — intervention group
Group type: COMPARATOR
Intervention: Cotton‐Huibregtse (CH) stent
Number of subjects: 57
Study 9014648 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-fat products
Number of subjects: 37
Study 9014648 — intervention group
Group type: COMPARATOR
Intervention: Full-fat equivalents
Number of subjects: 37
Study 9014648 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher activity level subjects
Number of subjects: 37
Study 1396651 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulation frequency of 50 Hz
Number of subjects: 10
Study 1396651 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulation frequency of 100 Hz
Number of subjects: 10
Study 3891710 — intervention group
Group type: EXPERIMENTAL
Intervention: amoxycillin 250 mg three times a day for seven days
Number of subjects: 37
Study 3891710 — intervention group
Group type: COMPARATOR
Intervention: trimethoprim 200 mg twice a day for seven days
Number of subjects: 37
Study 3891710 — intervention group
Group type: EXPERIMENTAL
Intervention: amoxycillin
Number of subjects: 37
Study 31702949 — intervention group
Group type: EXPERIMENTAL
Intervention: Online wellness intervention
Number of subjects: 382
Study 30861997 — intervention group
Group type: COMPARATOR
Intervention: Low-fat/high-protein diet (n = 132)
Number of subjects: 132
Study 30861997 — intervention group
Group type: COMPARATOR
Intervention: High-fat/high-protein diet (n = 35)
Number of subjects: 132
Study 30861997 — intervention group
Group type: COMPARATOR
Intervention: Dietary fiber intake ≥35 g (n = 15)
Number of subjects: 132
Study 28369055 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback via smartwatch
Number of subjects: 40
Study 28369055 — intervention group
Group type: COMPARATOR
Intervention: Control group (no feedback)
Number of subjects: 40
Study 25638438 — intervention group
Group type: EXPERIMENTAL
Intervention: Bibliotherapy intervention (reading Uncle Lightfoot, Flip that Switch: Overcoming Fear of the Dark, Academic Version) over 4 weeks
Number of subjects: 9
Study 25638438 — intervention group
Group type: EXPERIMENTAL
Intervention: Bibliotherapy intervention
Number of subjects: 9
Study 25638438 — intervention group
Group type: COMPARATOR
Intervention: Baseline control conditions (1, 2, or 3 weeks)
Number of subjects: 9
Study 23472104 — intervention group
Group type: EXPERIMENTAL
Intervention: Step pad training (intervention group) - computerized step pad system connected to TVs, recommended 2-3 sessions per week for 15-20 minutes each for eight weeks.
Number of subjects: 37
Study 21732100 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal surgery
Number of subjects: 94
Study 21732100 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal surgery
Number of subjects: 94
Study 18267042 — intervention group
Group type: EXPERIMENTAL
Intervention: A single dose of sulphadoxine/pyrimethamine (25 mg/kg of sulphadoxine/1.25 mg/kg of pyrimethamine)
Number of subjects: 140
Study 18267042 — intervention group
Group type: COMPARATOR
Intervention: Amodiaquine (10 mg/kg/day x 3 days)
Number of subjects: 140
Study 16909403 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D ultrasonography followed by 3D/4D ultrasonography
Number of subjects: 124
Study 16909403 — intervention group
Group type: COMPARATOR
Intervention: 2D ultrasonography alone
Number of subjects: 124
Study 16285277 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (8‐12 mg orally per day)
Number of subjects: 12
Study 16285277 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 12
Study 10900738 — intervention group
Group type: EXPERIMENTAL
Intervention: Double gloving
Number of subjects: 80
Study 10900738 — intervention group
Group type: COMPARATOR
Intervention: Single gloves
Number of subjects: 80
Study 10900738 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforced gowns
Number of subjects: 80
Study 10900738 — intervention group
Group type: COMPARATOR
Intervention: Normal gowns
Number of subjects: 80
Study 8824473 — intervention group
Group type: EXPERIMENTAL
Intervention: Microemulsion formulation of cyclosporine
Number of subjects: 21
Study 8824473 — intervention group
Group type: COMPARATOR
Intervention: Conventional formulation of cyclosporine
Number of subjects: 21
Study 1575336 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose propofol (0.08 mg/kg loading dose and 0.5 mg.kg‐1.h‐1 infusion)
Number of subjects: 10
Study 1575336 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-dose propofol (0.16 mg/kg loading dose and 1.0 mg.kg‐1.h‐1 infusion)
Number of subjects: 10
Study 1575336 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose propofol (0.32 mg/kg loading dose and 2.0 mg.kg‐1.h‐1 infusion)
Number of subjects: 10
Study 1575336 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Intralipid)
Number of subjects: 10
Study 3914701 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroxicam at 20 mg per day
Number of subjects: 20
Study 3914701 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen at 2,400 mg per day
Number of subjects: 20
Study 31829138 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction of labor (vaginal dinoprostone or amniotomy or oxytocin as appropriate)
Number of subjects: 318
Study 31829138 — intervention group
Group type: COMPARATOR
Intervention: Expectant management (await labor for at least 24 h unless indicated intervention)
Number of subjects: 318
Study 30368450 — intervention group
Group type: EXPERIMENTAL
Intervention: ToyBox-Scotland intervention (adapted ToyBox intervention)
Number of subjects: 6
Study 30368450 — intervention group
Group type: COMPARATOR
Intervention: Usual-care control group
Number of subjects: 6
Study 30368450 — intervention group
Group type: EXPERIMENTAL
Intervention: ToyBox-Scotland intervention
Number of subjects: 6
Study 26978587 — intervention group
Group type: EXPERIMENTAL
Intervention: real‐rTMS
Number of subjects: 20
Study 26978587 — intervention group
Group type: COMPARATOR
Intervention: sham‐rTMS
Number of subjects: 20
Study 24146070 — intervention group
Group type: EXPERIMENTAL
Intervention: Covariate adjustment for country and socio-demographic variables
Number of subjects: 0
Study 24146070 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptions of physical and mental health
Number of subjects: 0
Study 24146070 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV risk behavior variables
Number of subjects: 0
Study 24146070 — intervention group
Group type: EXPERIMENTAL
Intervention: CD4 count
Number of subjects: 0
Study 22683131 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 515
Study 22683131 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin
Number of subjects: 515
Study 20633037 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (TPM) 100 mg/day starting on day 1
Number of subjects: 261
Study 20633037 — intervention group
Group type: COMPARATOR
Intervention: Phenytoin (PHT) 1,000 mg on day 1 followed by 300 mg/day maintenance
Number of subjects: 261
Study 20633037 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (TPM)
Number of subjects: 261
Study 20633037 — intervention group
Group type: COMPARATOR
Intervention: Phenytoin (PHT)
Number of subjects: 261
Study 17127586 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein supplement (2 g x kg(‐1) body mass x day(‐1))
Number of subjects: 10
Study 17127586 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body low-magnitude (3.5 g), low-frequency (30 Hz) mechanical vibration (WBV) for 10 min each day
Number of subjects: 10
Study 17127586 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein supplement (2 g x kg(‐1) body mass x day(‐1)) + WBV
Number of subjects: 10
Study 17127586 — intervention group
Group type: COMPARATOR
Intervention: Whole-body vibration (WBV) alone
Number of subjects: 10
Study 15467036 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly dense breasts (i.e., > or =75% of the breast occupied by dense tissue)
Number of subjects: 504
Study 15467036 — intervention group
Group type: COMPARATOR
Intervention: Less than 25% of the breast occupied by dense tissue
Number of subjects: 504
Study 11712935 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invasive strategy of coronary angiography between 4 and 48 hours after randomization and revascularization when feasible (n = 1114)
Number of subjects: 2220
Study 11712935 — intervention group
Group type: COMPARATOR
Intervention: Conservative strategy of medical treatment and predischarge exercise tolerance testing (n = 1106)
Number of subjects: 2220
Study 11712935 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invasive strategy for patients with cTnI levels of 0.1 ng/mL or more (n = 1087)
Number of subjects: 2220
Study 11712935 — intervention group
Group type: COMPARATOR
Intervention: Conservative strategy for patients with cTnI levels of less than 0.1 ng/mL
Number of subjects: 2220
Study 11712935 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invasive strategy for patients with low-level (0.1-0.4 ng/mL) cTnI elevation
Number of subjects: 2220
Study 9130895 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist and FSH
Number of subjects: 323
Study 9130895 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 323
Study 8221426 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen half dose (162.5 mg per capsule, 2 capsules)
Number of subjects: 262
Study 8221426 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen full dose (325 mg per capsule, 2 capsules)
Number of subjects: 262
Study 8221426 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 identical capsules)
Number of subjects: 262
Study 3310451 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoglobulin therapy
Number of subjects: 74
Study 30088226 — intervention group
Group type: EXPERIMENTAL
Intervention: Group counseling sessions (6 sessions)
Number of subjects: 60
Study 30088226 — intervention group
Group type: COMPARATOR
Intervention: Control group (no counseling)
Number of subjects: 60
Study 29301558 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucine supplementation
Number of subjects: 440
Study 29301558 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril (ACE inhibitor)
Number of subjects: 440
Study 29301558 — intervention group
Group type: COMPARATOR
Intervention: Placebo for leucine
Number of subjects: 440
Study 29301558 — intervention group
Group type: COMPARATOR
Intervention: Placebo for perindopril
Number of subjects: 440
Study 26612089 — intervention group
Group type: EXPERIMENTAL
Intervention: Rejection of novel foods at 6 months of age
Number of subjects: 82
Study 26612089 — intervention group
Group type: EXPERIMENTAL
Intervention: Rejection of novel foods at 12 months of age
Number of subjects: 82
Study 25143169 — intervention group
Group type: EXPERIMENTAL
Intervention: Dezoxine 0.1 mg×kg(‐1) and dexmedetomidine 0.4 µg×kg(‐1)×h(‐1) until the end of the first ocular muscle correcting
Number of subjects: 60
Study 25143169 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 60
Study 21746751 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1: pre-fixed appointment plus standard leaflet
Number of subjects: 5360
Study 21746751 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2: pre-fixed appointment plus a more comprehensive booklet
Number of subjects: 5360
Study 21746751 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3: point (ii) plus the offer of a counselling session
Number of subjects: 5360
Study 21746751 — intervention group
Group type: COMPARATOR
Intervention: Group 4: invitation to contact the centre for information and arrange participation
Number of subjects: 5360
Study 20656748 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane preconditioning (10-minute exposure to isoflurane 2.5% followed by 5 minutes of washout)
Number of subjects: 45
Study 20656748 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (3 episodes of 1-minute aortic cross-clamping followed by 4 minutes of reperfusion after each episode)
Number of subjects: 45
Study 20656748 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preconditioning technique)
Number of subjects: 45
Study 18246841 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance telephone prompt group (157 GDPs)
Number of subjects: 315
Study 18246841 — intervention group
Group type: COMPARATOR
Intervention: Control group (158 GDPs)
Number of subjects: 315
Study 15833570 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking to control weight (5 lb gain)
Number of subjects: 0
Study 15833570 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking to control weight (10 lb gain)
Number of subjects: 0
Study 15833570 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking to control weight (20 lb gain)
Number of subjects: 0
Study 15833570 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no weight gain)
Number of subjects: 0
Study 11978336 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional workup and PET (CWU+PET)
Number of subjects: 188
Study 11978336 — intervention group
Group type: COMPARATOR
Intervention: Conventional workup (CWU)
Number of subjects: 188
Study 10492055 — intervention group
Group type: COMPARATOR
Intervention: Salmeterol dry powder, 50 microg twice daily
Number of subjects: 16
Study 10492055 — intervention group
Group type: COMPARATOR
Intervention: Formoterol dry powder, 12 microg twice daily
Number of subjects: 16
Study 8610621 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination lovastatin and probucol
Number of subjects: 0
Study 8610621 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 2015146 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine (with adrenaline) 3 mg/kg body weight (Group A)
Number of subjects: 22
Study 2015146 — intervention group
Group type: COMPARATOR
Intervention: 0.5% plain bupivacaine 3 mg/kg body weight (Group B)
Number of subjects: 22